Status:

COMPLETED

What is the Optimal Training Model for Cervical Awareness?

Lead Sponsor:

Izmir City Hospital

Conditions:

HPV Infection

Cervical Cancer

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Cervical cancer represents the fourth most prevalent malignant disease and the fourth leading cause of mortality among women on a global scale. Despite screening and preventive vaccination efforts, ce...

Detailed Description

A number of studies have been conducted with the aim of raising awareness about HPV and cervical cancer. However, there is currently no evidence-based consensus on the most effective method of educati...

Eligibility Criteria

Inclusion

  • Being over 18 and under 40
  • Female doctors, female nurses and female health technicians
  • Working in our hospital
  • Having sufficient mental capacity
  • Not having a visual or auditory disability
  • Volunteering to participate in the study

Exclusion

  • Under 18 and over 40
  • Not being a healthcare worker
  • Not having enough mental capacity
  • Having a visual or auditory disability
  • Patients who did not volunteer to participate in the study

Key Trial Info

Start Date :

August 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2024

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT06562595

Start Date

August 15 2024

End Date

September 30 2024

Last Update

May 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Izmir City Hospital

Izmir, Turkey (Türkiye)